In hepatocellular carcinoma, nicotinamide phosphoribosyltransferase (NAMPT) can also increase the expression of PD-L1 by promoting the phosphorylation of STAT1, thereby mediating the immune escape of liver cancer [8]. The gene discussed is NAMPT; the disease is hepatocellular carcinoma.